Use of Thiazolidinediones and the Risk of Colorectal Cancer in Patients With Diabetes: A nationwide, population-based, case-control study

OBJECTIVE: Preclinical data suggest that peroxisome proliferator–activated receptor γ (PPARγ) agonists have antineoplastic effects in colorectal cancer. We aimed to assess the association between the use of synthetic PPARγ agonists, represented by thiazolidinediones (TZDs), and the risk of developin...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Shih-Wei, Tsan, Yu-Tse, Chen, Jong-Dar, Hsieh, Hui-I, Lee, Chang-Hsing, Lin, Hsien-Ho, Wang, Jung-Der, Chen, Pau-Chung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3554275/
https://www.ncbi.nlm.nih.gov/pubmed/23043163
http://dx.doi.org/10.2337/dc11-2197

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3554275/
https://www.ncbi.nlm.nih.gov/pubmed/23043163
http://dx.doi.org/10.2337/dc11-2197

Ejemplares similares